Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50199896 (3-((2R,3R,7S,9-alpha-S)-2,3-dimethyl-7-phenyl-octa...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet  | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 0.570 | -52.8 | 0.530 | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50199914 (3-((7R,8R,9alphaR)-2-benzyl-7,8-dimethyl-octahydro...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 1.10 | -51.1 | 11 | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50199913 (((7R,8R,9alphaR)-8-(3-hydroxyphenyl)-7,8-dimethyl-...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 2 | -49.7 | 21 | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50199912 (3-((3S,7R,8R,9alphaR)-2,7,8-trimethyl-3-phenyl-oct...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 3.30 | -48.4 | 26 | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50199943 (3-((3S,7R,8R,9alphaR)-7,8-dimethyl-3-phenyl-octahy...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 3.60 | -48.2 | 12 | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50199934 (3-((7R,8R,9alphaR)-7,8-dimethyl-2-phenethyl-octahy...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 5.5 | -47.1 | 21 | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50199907 (3-((3S,7R,8R,9alphaR)-3-benzyl-7,8-dimethyl-octahy...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 8.90 | -46.0 | 29 | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50199896 (3-((2R,3R,7S,9-alpha-S)-2,3-dimethyl-7-phenyl-octa...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 8.90 | -46.0 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50199912 (3-((3S,7R,8R,9alphaR)-2,7,8-trimethyl-3-phenyl-oct...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 12 | -45.2 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50199943 (3-((3S,7R,8R,9alphaR)-7,8-dimethyl-3-phenyl-octahy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 18 | -44.2 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50199913 (((7R,8R,9alphaR)-8-(3-hydroxyphenyl)-7,8-dimethyl-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 25 | -43.4 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50199896 (3-((2R,3R,7S,9-alpha-S)-2,3-dimethyl-7-phenyl-octa...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 30 | -42.9 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50199907 (3-((3S,7R,8R,9alphaR)-3-benzyl-7,8-dimethyl-octahy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 36 | -42.5 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50199914 (3-((7R,8R,9alphaR)-2-benzyl-7,8-dimethyl-octahydro...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 44 | -42.0 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50199907 (3-((3S,7R,8R,9alphaR)-3-benzyl-7,8-dimethyl-octahy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 85 | -40.4 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50199943 (3-((3S,7R,8R,9alphaR)-7,8-dimethyl-3-phenyl-octahy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 88 | -40.3 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50199934 (3-((7R,8R,9alphaR)-7,8-dimethyl-2-phenethyl-octahy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 112 | -39.7 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50199914 (3-((7R,8R,9alphaR)-2-benzyl-7,8-dimethyl-octahydro...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 139 | -39.1 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50199913 (((7R,8R,9alphaR)-8-(3-hydroxyphenyl)-7,8-dimethyl-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 190 | -38.4 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50199934 (3-((7R,8R,9alphaR)-7,8-dimethyl-2-phenethyl-octahy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 242 | -37.8 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50199912 (3-((3S,7R,8R,9alphaR)-2,7,8-trimethyl-3-phenyl-oct...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 716 | -35.1 | n/a | n/a | n/a | n/a | n/a | 7.8 | 25 |
Adolor Corporation US Patent | Assay Description The receptor binding method (DeHaven and DeHaven-Hudkins, 1998) was a modification of the method of Raynor et al. (1994). | US Patent US8580788 (2013) BindingDB Entry DOI: 10.7270/Q2N29VKK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
